Damian Sousa »

Protagonist Therapeutics shares owned by Damian Sousa

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Damian Sousa from 13F filings

Historical chart of Damian Sousa investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Damian Sousa consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Damian Sousa

Quarter filed Position value Share count Share price at filing
2024-09-30 $14M 294k 46.23
2024-06-30 $13M 358k 35.20

More positions owned by Damian Sousa

Accenture Plc-cl A Common Stock
Microsoft Corp Common Stock (MSFT)
Broadcom Common Stock (AVGO)
Jpmorgan Chase & Co Common Stock (JPM)
Cencora Common Stock (COR)
Rb Global Common Stock (RBA)
Baker Hughes Common Stock (BKR)
Ares Management Corp - A Common Stock (ARES)
Goldman Sachs Group Common Stock (GS)
Wabtec Corp Common Stock (WAB)
Axon Enterprise Common Stock (AXON)
Eaton Corp Common Stock (ETN)
Pnc Financial Services Group Common Stock (PNC)
Chevron Corp Common Stock (CVX)
Royal Caribbean Cruises Common Stock (RCL)

View all positions for Damian Sousa

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
BlackRock
Vanguard Group
Johnson & Johnson
State Street Corporation
Leucadia National Corporation
BVF
Pacer Advisors
Geode Capital Management
Perceptive Advisors
T. Rowe Price Associates
Kynam Capital Management
Invesco
Goldman Sachs Group

View all funds holding Protagonist Therapeutics